Quality vs. Cost: Are Pharma Companies Missing a Trick to Reduce R&D Expenses?
In the high-stakes world of pharmaceutical research and development (R&D), costs are skyrocketing. But what if better quality management could be the key to unlocking significant savings? Recent research indicates that tracking and analyzing the 'costs of quality' within clinical development, an often-overlooked area, could be a game-changer.